Skip to content

Pelagos Insurance Capital stock

PLGONYSE

Pelagos Insurance Capital Limited, Financial ServicesISIN BMG3398L1182

$28.83▲ $0.86 (+3.1%)Closing price of 12 Nov 2026

84Score 84 out of 100, Strong

Turn on early warning

Price and trend

76 / 100

Price history

+43% since 2026

The chart shows daily closing prices since 14 Apr 2026, adjusted for stock splits and excluding dividends. Click into the chart to set a price alert at that price.

Momentum

Overheated: the price has risen very quickly lately (RSI 77).

Distance to the high

The price is at its 52-week high. Largest decline since 14 Apr 2026: 12% (July 2026 to August 2026).

Chart figures for advanced users
SMA 50$25.27
Average price of the last 50 trading days, shows the short-term trend.
SMA 200$28.83
Average price of the last 200 trading days, shows the long-term trend.
RSI (14)77
Relative strength over the last 14 days on a scale from 0 to 100. Above 70 the price counts as overheated, below 30 as sharply fallen.
MACDabove the signal line
Compares a fast and a slow price average. Above its signal line momentum is rising, below it momentum is fading.
Support$20.14
The lowest closing price of the last twelve months.
Resistance$28.83
The highest closing price of the last twelve months.
Market cap
$2.31B
Div. yield
2.15%
12 months
5.9
7.3
on earnings for the next twelve months ($3.85 per share)
Fair value
$59.49

Snapshot

Computed from the data by fixed rules, no AI

  • Pelagos Insurance Capital Limited belongs to the Insurance (Diversified) industry (Bermuda) and, with a market value of $2.39B, is number 40 of 43 companies in its industry on MEQIRI.
  • In fiscal 2025 it earned $225.5M (up 99% year on year).
  • MEQIRI Score 84 out of 100 (Strong): rank 32 of 976 in Financial Services, median 68.
Show more
  • The P/E is 6.1 (Insurance (Diversified) median 13.9, own median of recent years 9.5).
  • Our model puts fair value at $59.49, with the price 53% below it.

In plain words

The numbers on this page in plain words, written by an AI

Strengths

  • Modestly valuedP/E 6.1, Insurance (Diversified) median 13.9, own median 9.5.Valuation 100
  • High return on equityReturn on equity 17.3% over the last 12 months.Profitability 58
  • Below fair valuePrice 53% below the fair value of $59.49.Valuation 100

Weaknesses

None of our weakness checks flags anything. Crash risk is measured separately.

84/ 100
MEQIRI Score
Strong

Its standout strengths are growth and valuation.

Daily figure as of 12 Nov 2026

How the score is calculated

Score overview

Score since yesterday from 83 to 84.

The fundamentals are strong overall.

Profit consistency100% of years
Cash conversion (free cash flow to earnings)not used for financials
ROE (12 months)17.3%
Positive free cash flownot used for financials
How this category is measured

Score history

The full history of up to 20 years comes with MEQIRI Pro.

See plans

Valuation

Valuation signal

Significantly undervalued
Price
$27.97
Fair value
$59.49
Gap to fair value
−53%

Closing price of 11 Nov 2026, used by the daily score.

In our model the price counts as cheap below $45.76 and expensive above $84.99 (uncertainty medium, based on the price swings of the past year).

The two parts of the fair value come to $53.50 (excess return model) and $65.49 (industry comparison), and the gap between them shows how uncertain the estimate is. The price is below both.

Calculated with a cost of equity of 8.8%. At 9.8% the fair value would be $55.04, at 7.8% it would be $66.18.

Valuation metrics

1.1
17.3%
last 12 months, profit over average equity
Fair value (model)
$59.49
Earnings part $65.49 (earnings per share $4.71 × 13.9)

Half from the excess return model, half from earnings times the industry P/E (13.9).

Calculate with your own assumptions

Company performance

This shows several years of history with an automatic assessment.

Revenue

6 years

In the twelve months to 30 Jun 2026, revenue fell 14.6% on the twelve months before. Revenue has grown strongly since 2020, at around 23% per year.

Margins

6 years
  • Operating margin
  • Net margin

In fiscal 2025: operating 13%, net 10%. Banks and insurers have no gross margin, and their net margin is not comparable with other industries. The score leaves both out. Last 12 months: net 19%.

Debt & balance sheet

latest quarter
0.32
Equity
$2.22B
0.92
Cash & equivalents
$517.1M

For banks and insurers, deposits and liabilities are the business. Debt to equity and the current ratio say little here, and the score does not rate them.

Earnings

Next earnings
24 Feb 2027in 104 days
Last reported
11 Nov 2026EPS reported $1.00 (expected $0.72)above expectations

Analyst estimates

Earnings estimates have barely changed since 15 Oct 2026.

Fiscal 20265 analysts
Earnings per share
$3.060.0%
Revenue
$3.79B0.0%
Fiscal 20275 analysts
Earnings per share
$3.970.0%
Revenue
$3.99B0.0%

MEQIRI has stored the estimates since 15 Oct 2026. Until 30 days are available, the card shows the change since that day. Mean estimate according to Financial Modeling Prep. No price target and no recommendation.

Company outlook confirmed

Share price after the results: −2.0%

Expectations confirmed: loss ratio in the mid-40% range, third-quarter net earned premiums similar to the second quarter in Insurance and $130 million to $160 million in Reinsurance.

Supporting passage from the call, verbatim
“Looking into the third quarter, we expect net earned premiums to be similar to our second quarter in Insurance, and $130 million to $160 million in Reinsurance.”

The outlook is not part of the score and not a recommendation to buy or sell.

From the earnings call on 13 Aug 2026 (fiscal Q2 2026), read by AI.

Insiders

Open-market purchases and sales by executives, board members and major holders

All insider purchases

No open-market purchases or sales in the last 6 months.

Source: Form 4 filings with the US Securities and Exchange Commission. Grants, option exercises, gifts and tax withholdings are hidden. Not a recommendation to buy.

What happened at Pelagos Insurance Capital

The key events of the last six months from our own data. A click takes you to the matching card.

Sector comparison

976 rated companies in Financial Services

Rank 32 of 976
32/ 976
This company
84
Sector median
68

Categories against the sector median

ProfitabilityMedian of 976 companies58 (median 57)1 above the median
GrowthMedian of 976 companies100 (median 67)33 above the median
FundamentalsMedian of 976 companies91 (median 80)11 above the median
ValuationMedian of 929 companies with a value100 (median 73)27 above the median
StabilityMedian of 976 companies80 (median 78)2 above the median
Capital allocationMedian of 976 companies83 (median 56)27 above the median
Technical analysisMedian of 976 companies76 (median 70)6 above the median
MomentumMedian of 976 companies94 (median 70)24 above the median

The median is the middle value: half of the companies in the sector lie above it, half below. Categories with too few comparable companies are left out.

Competitors in Insurance (Diversified)

The next larger and next smaller companies by market value

All 43 Insurance (Diversified) stocks

ETFs that hold Pelagos Insurance Capital

Held by 2 ETFs on Xetra. Shown per index: the ETF with the largest weight.

ETFWeightCostFund size
Avantis Global Small Cap Value UCITS ETFAVWS0.08%0.39%€1.47B
Invesco Global Buyback Achievers UCITS ETFBBCK0.02%0.39%€188.08M

Holdings as reported by the funds via FMP, excluding swap ETFs (their holdings are only collateral).

Data status and sources

Score
Daily value of 12 Nov 2026, recalculated nightly
Price
Closing price of 12 Nov 2026
Latest annual report
Fiscal year 2025, period end 31 Dec 2025
Source
Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.

Mandatory disclosures for this rating

  • ; time horizon around 12 months
  • Rated Strong, published since 7 Nov 2026 (in the score history since 15 Oct 2026)
  • Valuation signal Undervalued since 7 Nov 2026
  • End-of-day prices, metrics cached for up to 24 hours
  • Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
  • Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
  • Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.

MEQIRI counts visits without cookies. With your consent we remember for 90 days where you came from, also in your account, count page changes and time on page, recognise your next visit and load the Meta Pixel, which measures our advertising. You can withdraw your consent at any time under Cookie settings. Privacy